$0.85
-0.03 (-2.99%)
Market Cap
$77.1M
Shares Outstanding
88,275,204
Institutional Holders
7
Total Inst. Value
$109K
% of Float Held
2.5%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | UBS Group AG | $46K | 49,745 |
| 2 | IFP Advisors, Inc | $21K | 22,215 |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $19K | 20,539 |
| 4 | Yakira Capital Management, Inc. | $11K | 11,999 |
| 5 | Tabor Asset Management, LP | $11K | 11,999 |
| 6 | OSAIC HOLDINGS, INC. | $325 | 350 |
| 7 | BANK OF AMERICA CORP /DE/ | $0 | 160 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| UBS Group AG | +25K | $46K |
| GEODE CAPITAL MANAGEMENT, LLC | +8K | $19K |
Top Sellers
| Fund | Shares Removed | Value |
|---|---|---|
| OSAIC HOLDINGS, INC. | -5K | $325 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold CTOR?
As of Q1 2025, 7 institutional investors report holding CTOR (Citius Oncology, Inc.) in their 13F filings.
What percentage of Citius Oncology, Inc. is owned by institutions?
Institutional investors hold approximately 2.5% of Citius Oncology, Inc.'s float as reported in SEC 13F filings.
Which hedge fund owns the most CTOR?
The largest institutional holder of CTOR is UBS Group AG with $46K in shares.
Are institutions buying or selling CTOR?
This quarter, 1 institutions opened new positions in CTOR and 6 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.